These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 33646050)
81. Assessment of healthcare students' views on pharmacogenomics at the University of Minnesota. Moen M; Lamba J Pharmacogenomics; 2012 Oct; 13(13):1537-45. PubMed ID: 23057552 [TBL] [Abstract][Full Text] [Related]
82. Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Mai Y; Mitropoulou C; Papadopoulou XE; Vozikis A; Cooper DN; van Schaik RH; Patrinos GP Per Med; 2014 Jan; 11(1):15-26. PubMed ID: 29751393 [TBL] [Abstract][Full Text] [Related]
83. Stakeholder analysis in pharmacogenomics and genomic medicine in Greece. Mitropoulou C; Mai Y; van Schaik RH; Vozikis A; Patrinos GP Public Health Genomics; 2014; 17(5-6):280-6. PubMed ID: 25228172 [TBL] [Abstract][Full Text] [Related]
84. Pre-clinical Medical Students' Attitudes Toward Physical Medicine and Rehabilitation. Le B; Parziale JR R I Med J (2013); 2019 Apr; 102(3):26-28. PubMed ID: 30943668 [TBL] [Abstract][Full Text] [Related]
85. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
86. The current and future state of pharmacogenomics medical education in the USA. Nickola TJ; Green JS; Harralson AF; O'Brien TJ Pharmacogenomics; 2012 Sep; 13(12):1419-25. PubMed ID: 22966890 [TBL] [Abstract][Full Text] [Related]
87. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program. Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264 [TBL] [Abstract][Full Text] [Related]
88. The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Gottesman O; Scott SA; Ellis SB; Overby CL; Ludtke A; Hulot JS; Hall J; Chatani K; Myers K; Kannry JL; Bottinger EP Clin Pharmacol Ther; 2013 Aug; 94(2):214-7. PubMed ID: 23588317 [No Abstract] [Full Text] [Related]
89. Evidence that personal genome testing enhances student learning in a course on genomics and personalized medicine. Salari K; Karczewski KJ; Hudgins L; Ormond KE PLoS One; 2013; 8(7):e68853. PubMed ID: 23935898 [TBL] [Abstract][Full Text] [Related]
90. Pharmacogenomics primer course for first professional year pharmacy students. Nickola TJ; Munson AM Pharmacogenomics; 2014 Jan; 15(1):39-48. PubMed ID: 24329189 [TBL] [Abstract][Full Text] [Related]
91. The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada. Bashir NS; Ungar WJ Genome; 2015 Dec; 58(12):527-40. PubMed ID: 26623513 [TBL] [Abstract][Full Text] [Related]
93. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation. Ciarleglio AE; Ma C Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583 [TBL] [Abstract][Full Text] [Related]
94. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine. Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145 [TBL] [Abstract][Full Text] [Related]
95. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation. Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876 [TBL] [Abstract][Full Text] [Related]
96. Pharmacogenomics education and perceptions: is there a gap between internal medicine resident and attending physicians? Rohrer Vitek CR; Giri J; Caraballo PJ; Curry TB; Nicholson WT Pharmacogenomics; 2021 Mar; 22(4):195-201. PubMed ID: 33538610 [No Abstract] [Full Text] [Related]
97. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen. Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652 [No Abstract] [Full Text] [Related]
98. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review). Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205 [TBL] [Abstract][Full Text] [Related]
99. Genomics Testing and Personalized Medicine in the Preoperative Setting. Gabriel RA; Burton BN; Urman RD; Waterman RS Surg Oncol Clin N Am; 2020 Jan; 29(1):73-86. PubMed ID: 31757315 [TBL] [Abstract][Full Text] [Related]
100. Pharmacogenomics Clinical Annotation Tool (PharmCAT). Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]